Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: This case was reported by a physician and described the occurrence of meningoencephalitis in a 11-year-old patient who received BEXSERO. The patient''s past medical history included asplenia and spherocytosis. Concurrent medical conditions included headache. Concomitant products included FLUVIRIN. On an unknown date, the patient received the 1st dose of BEXSERO. On an unknown date, an unknown time after receiving BEXSERO, the patient experienced meningoencephalitis (serious criteria hospitalization and GSK medically significant) and streptococcal pharyngitis. On an unknown date, the outcome of the meningoencephalitis and streptococcal pharyngitis were unknown. It was unknown if the reporter considered the meningoencephalitis and streptococcal pharyngitis to be related to BEXSERO. Additional details were provided as follows: In July 2014, the patient had undergone splenectomy. The patient had headache prior to vaccination with BEXSERO. The patient experienced aseptic meningoencephalitis and Group A strep pharyngitis. The patient was receiving not any penicillin prophylaxis at the time of reporting. Follow up information was received on 6th April 2016: It was concluded that the symptoms experienced by the patient were very unlikely related to BEXSERO and that the patient should receive the 2nd dose of the vaccine.
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166